

Phortas Representative at ERDERA General Assembly Meeting
We are proud to share that Dr. Darius-Jean Namdjou, Director and Senior Regulatory Lead at Phortas, participated in the General Assembly Meeting of ERDERA, held from 29–31 October 2025 at the Amsterdam University Medical Center (UMC). ERDERA – the European Rare Diseases Research Alliance  – is a European partnership that unites over 170 public and private organisations across 37 countries around a common goal: transforming cutting-edge science into tangible benefits for the t


Phortas ISO 9001:2015 certified!
Phortas is proud to announce that at the end of July 2025 our Quality Management System was officially certified according to the ISO9001:2015 standard. This certification reinforces our commitment to delivering the highest quality standards in regulatory affairs consulting and development consulting. It brings clear benefits to our clients, including: Increased customer trust and satisfaction – Clients can rely on our structured processes and consistent service delivery liv


Phortas at BIO International Convention 2025!
Phortas is thrilled to be attending and sharing our expertise at this year’s BIO International Convention , taking place in Boston from...


Accelerating Clinical Trials in Europe, RAPS Euro Convergence 2025
Our Managing Director, Jasmina Savic , will be leading the session "Accelerating Clinical Trials in the EU" Â on 14 May 2025 at this...


Phortas at ATMP Scientific Symposium
We are excited to share that Dr. Darius-Jean Namdjou, our Director, Senior Regulatory Lead at Phortas, recently participated in the...


Insights from the EMA Big Data Steering Group Workshop
We are thrilled to share that Jasmina Savic, our Managing Director at Phortas, recently participated in the European Medicines Agency...


Phortas Joins EU-X-CT Initiative: Pioneering Cross-Border Clinical Trials
Phortas has joined EU-X-CT: An initiative that seeks to enable and facilitate cross-border access to clinical trials for patients in...


Canada to potentially join parallel Scientific Advice with EMA and FDA for Complex Generics
Three years ago The FDAÂ and the European Medicines Agency (EMA) have initiated a pilot program aimed at offering parallel scientific...


Phortas Members to Present at RAPS Euro Convergence 2024 in Berlin
We are delighted to announce that our two senior Phortas members will be presenting at RAPS Euro Convergence, scheduled from 06-08 May...


Phortas is Thrilled to Announce Our Participation at BioSpain 2023!
At Phortas, we are excited to share some remarkable news with you - we will be attending BioSpain 2023, one of Europe's premier...


